EFFECTS OF SYNTETIC CANNABINOID RECEPTOR LIGANDS WIN 55.212-2 AND ANANDAMID UPON IN VITRO ACTIVITY OF IMMUNOCOMPETENT CELLS

EFFECTS OF SYNTETIC CANNABINOID RECEPTOR LIGANDS WIN 55.212-2 AND ANANDAMID UPON IN VITRO ACTIVITY OF IMMUNOCOMPETENT CELLS

Abstract. Ability of cannabinoid receptor ligands WIN 55.212-2 and anandamid to inhibit synthesis of TNFα and IL-8 was studied in healthy donors and men with allergic disorders. To establish mechanism of action for investigated substances, the selective antagonists of the СВ1-receptor (SR141716A) an...

Full description

Bibliographic Details
Main Author:	E. G. Lobanova
Format:	Article
Language:	Russian
Published:	St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 2014-07-01
Series:	Медицинская иммунология
Subjects:	immune cells tnfα il-8 cannabinoid receptor ligands win-55.212-2 anandamid
Online Access:	https://www.mimmun.ru/mimmun/article/view/315

Similar Items

Cannabinoid WIN55,212-2 reprograms monocytes and macrophages to inhibit LPS-induced inflammation
by: Mario Pérez-Diego, et al.
Published: (2023-03-01)

Minimum Alveolar Concentration of Isoflurane in Rats Chronically Treated with the Synthetic Cannabinoid WIN 55,212-2
by: Julio Raul Chavez-Monteagudo, et al.
Published: (2022-03-01)

A male mouse model of WIN 55,212–2 self-administration to study cannabinoid addiction
by: María del Mar Cajiao-Manrique, et al.
Published: (2023-03-01)

WIN 55,212-2 Inhibits the Epithelial Mesenchymal Transition of Gastric Cancer Cells via COX-2 Signals
by: Xiangshu Xian, et al.
Published: (2016-11-01)

Synthetic cannabinoid WIN 55,212–2 inhibits growth and induces cell death of oral and pancreatic stem-like/poorly differentiated tumor cells
by: Meng-Wei Ko, et al.
Published: (2022-10-01)

Role of Nitric Oxide in the Antipruritic Effect of WIN 55,212-2, a Cannabinoid Agonist
by: Oyku Zeynep Gercek, et al.
Published: (2020-07-01)

WIN 55,212-2 shows anti-inflammatory and survival properties in human iPSC-derived cardiomyocytes infected with SARS-CoV-2
by: Luiz Guilherme H. S. Aragão, et al.
Published: (2021-10-01)

Repeated Administration of the Cannabinoid WIN Alters the Isoflurane-Sparing Effect of Morphine and Dexmedetomidine
by: José Antonio Ibancovichi, et al.
Published: (2023-04-01)

THC exposure during adolescence increases impulsivity-like behavior in adulthood in a WIN 55,212-2 self-administration mouse model
by: María del Mar Cajiao-Manrique, et al.
Published: (2023-05-01)

The effect of spinally administered WIN 55,212-2, a cannabinoid agonist, on thermal pain sensitivity in diabetic rats
by: Samane Jahanabadi, et al.
Published: (2016-04-01)

Consequences of Adolescent Exposure to the Cannabinoid Receptor Agonist WIN55,212-2 on Working Memory in Female Rats
by: Erin K. Kirschmann, et al.
Published: (2017-07-01)

WIN55,212-2, a Dual Modulator of Cannabinoid Receptors and G Protein-Coupled Inward Rectifier Potassium Channels
by: Dongchen An, et al.
Published: (2021-04-01)

Effect of WIN55-212-2 and Consequences of Extinction Training on Conditioned Fear Memory in PTSD Male Rats
by: Malihe Ghasemi, et al.
Published: (2017-11-01)

Lithium Attenuates Cannabinoid-Induced Dependence in the Animal Model: Involvement of Phosphorylated ERK1/2 and GSK-3β Signaling Pathways
by: Hamid Reza Rahimi, et al.
Published: (2014-09-01)

Behavioral, biochemical and histopathological toxic profiles induced by sub-chronic cannabimimetic WIN55, 212–2 administration in mice
by: Ghada A. Omran, et al.
Published: (2023-02-01)

Microinjection of WIN55,212-2 as a Cannabinoid Agonist into the Basolateral Amygdala Induces Sensitization to Morphine in Rats
by: Marzieh Molaei, et al.
Published: (2014-11-01)

Neurotherapeutic potential of synthetic cannabinoid receptor agonist, WIN55,212-2 on Aluminium chloride and D-galactose- induced cognitive impairments in male Wistar rats
by: Onesimus, Mahdi
Published: (2021)

EFFECT OF CANNABINOIDS ON TESTICULAR ISCHEMIA-REPERFUSION INJURY IN RAT
by: R. Rabani, et al.
Published: (2006-12-01)

The Role of Ion Channels and Intracellular Signaling Cascades in the Inhibitory Action of WIN 55,212-2 upon Hyperexcitation
by: Sergei A. Maiorov, et al.
Published: (2024-06-01)

Anandamide Alters Barrier Integrity of Bovine Vascular Endothelial Cells during Endotoxin Challenge
by: Carsten C. F. Walker, et al.
Published: (2022-07-01)

Peripheral Endogenous Cannabinoid Levels Are Increased in Schizophrenia Patients Evaluated in a Psychiatric Emergency Setting
by: Stéphane Potvin, et al.
Published: (2020-06-01)

Influence of Inhibition of COX-2-Dependent Lipid Metabolism on Regulation of UVB-Induced Keratinocytes Apoptosis by Cannabinoids
by: Piotr Wójcik, et al.
Published: (2022-06-01)

A MALE MOUSE MODEL OF WIN 55,212-2 SELF-ADMINISTRATION TO STUDY CANNABINOID ADDICTION
by: María Del Mar Cajiao-Manrique, et al.
Published: (2023-10-01)

Enhanced self-administration of the CB1 receptor agonist WIN55,212-2 in olfactory bulbectomized rats: evaluation of possible serotonergic and dopaminergic underlying mechanisms
by: Petra eAmchova, et al.
Published: (2014-03-01)

Fuzzy Win-Win: A Novel Approach to Quantify Win-Win Using Fuzzy Logic
by: Ghada A. Altarawneh, et al.
Published: (2022-03-01)

The Influence of Anandamide on the Anterior Pituitary Hormone Secretion in Ewes—Ex Vivo Study
by: Dorota Tomaszewska-Zaremba, et al.
Published: (2020-04-01)

The role of cannabinoid CB1 receptors in the antinociceptive and reparative actions of mesenchymal stem cells in rats with peripheral neuropathic pain
by: Anna‐Maria V. Yerofeyeva, et al.
Published: (2023-09-01)

Altered Anandamide Degradation in Attention Deficit Hyperactivity Disorder
by: J Gordon Millichap
Published: (2009-06-01)

Cannabinoid Receptor Agonist WIN55, 212-2 Attenuates Injury in the Hippocampus of Rats after Deep Hypothermic Circulatory Arrest
by: Ming-Huan Yu, et al.
Published: (2023-03-01)

RNAi Screen Identifies AXL Inhibition Combined with Cannabinoid WIN55212-2 as a Potential Strategy for Cancer Treatment
by: Feifei Li, et al.
Published: (2024-11-01)

Polymeric Nanomicelles Loaded with Anandamide and Their Renal Effects as a Therapeutic Alternative for Hypertension Treatment by Passive Targeting
by: Virna Margarita Martín Giménez, et al.
Published: (2023-01-01)

Cannabinoids in Breast Cancer: Differential Susceptibility According to Subtype
by: Cristina Ferreira Almeida, et al.
Published: (2021-12-01)

A Modeling Approach for Getting to Win-Win in Industrial Collaboration under Strategic Coopetition
by: Vik Pant, et al.
Published: (2019-07-01)

Association of the c.385C>A (p.Pro129Thr) polymorphism of the fatty acid amide hydrolase gene with anorexia nervosa in the Japanese population
by: Tetsuya Ando, et al.
Published: (2014-07-01)

Design, Synthesis, and Pharmacological Evaluation of Novel Quinolone Aryl Sulfonamide Derivatives as Potent GPR55 Antagonists
by: Paula Morales, et al.
Published: (2019-09-01)

Capsazepine, a Transient Receptor Potential Vanilloid Type 1 (TRPV1) Antagonist, Attenuates Antinociceptive Effect of CB1 Receptor Agonist, WIN55,212-2, in the Rat Nucleus Cuneiformis
by: Abbas Haghparast, et al.
Published: (2011-08-01)

Capsazepine, a Transient Receptor Potential Vanilloid Type 1 (TRPV1) Antagonist, Attenuates Antinociceptive Effect of CB1 Receptor agonist, WIN55,212-2, in the Rat Nucleus Cuneiformis
by: Asghar Parvishan, et al.
Published: (2011-08-01)

Effect of central administration of indomethacin on anandamide-induced GnRH/LH secretion in the hypothalamus of anoestrous ewes
by: Tomaszewska-Zaremba Dorota, et al.
Published: (2024-07-01)

Association of anandamide and 2-arachidonoylglycerol concentrations with clinical features and body mass index in eating disorders and obesity
by: Isabel Baenas, et al.
Published: (2023-01-01)

The effect of aerobic exercise with ozone and stem cell on anandamide concentration in desert rat with osteoarthritis
by: Maryam Rezaei, et al.
Published: (2022-04-01)